The Evidence-Based Benefits of Regular Sauna Use

By Telos Wellness Editorial Team. Last reviewed 2026-05-12.

Sauna benefits supported by the strongest current evidence are cardiovascular: regular bathing is associated with lower all-cause and cardiovascular mortality in the KIHD cohort of 2,315 middle-aged Finnish men (Laukkanen et al., JAMA Intern Med, 2015). The 2023 Kunutsor meta-analysis confirms the direction. Benefits with moderate evidence include blood pressure reduction, improved endothelial function, and post-exercise recovery. Weight loss and toxin elimination claims have weak or insufficient support. This article grades each benefit by literature quality.

How this article grades the evidence

Sauna research is uneven. Some outcomes — notably cardiovascular and all-cause mortality — have multi-decade prospective cohort data and a 2023 updated meta-analysis behind them. Others — weight loss and heavy-metal detoxification — rest on weak or extrapolated evidence and a body of marketing copy that often overstates what the primary literature reports. The grading approach below separates the two.

Source hierarchy (systematic review → cohort → mechanistic → marketing)

Claims in this article are weighted by source class. Systematic reviews and meta-analyses (Hussain & Cohen, 2018; Kunutsor & Laukkanen, 2023) sit at the top. Prospective cohort studies (the Kuopio Ischaemic Heart Disease Risk Factor study — KIHD) follow. Mechanistic and physiological trials (Iguchi et al., 2012; Kihara et al., 2002) follow next, and marketing claims unsupported by primary literature are excluded.

The GRADE-style grading scale used here

Each benefit is graded Strong, Moderate, Weak or Insufficient. Strong indicates multiple cohort or RCT studies with consistent direction and a recent meta-analysis. Moderate indicates one large cohort or several smaller trials with consistent direction. Weak indicates limited or heterogeneous trials with small samples. Insufficient indicates no randomised controlled trial of meaningful size and only mechanistic or anecdotal support.

A note on traditional-sauna vs infrared-sauna data

The majority of long-term cohort data — including the KIHD findings — come from traditional Finnish saunas operating at 80–100°C (Hussain & Cohen, 2018). Infrared-specific cohort data of comparable length do not currently exist. Short-term infrared trials, notably Beever (2009), report cardiovascular biomarker changes consistent with traditional-sauna data, but the strongest mortality association is established only in the traditional-sauna literature. Hedges are applied throughout where infrared-specific data are extrapolated.

Cardiovascular and all-cause mortality — STRONG evidence

The cardiovascular and all-cause mortality association is the most robust finding in the sauna literature. Hazard ratios are reported with 95% confidence intervals, and the dose-response gradient is consistent across frequency and duration strata.

The KIHD cohort and what it shows

The KIHD prospective cohort (n=2,315 Finnish men aged 42–60, median follow-up 20.7 years) reports a hazard ratio of 0.60 (95% CI 0.46–0.78) for all-cause mortality in men using a sauna 4–7 times per week compared with once weekly (Laukkanen et al., JAMA Intern Med, 2015). Cardiovascular mortality hazard ratio was 0.50. The cohort is observational; residual confounding from physical activity and socioeconomic status was statistically adjusted but cannot be excluded.

All-cause mortality is defined as death from any cause across the follow-up window. A hazard ratio of 0.60 indicates a 40% lower instantaneous risk in the high-frequency group at any time point, conditional on survival to that point. Adjustment variables in the KIHD model included age, body mass index, smoking status, alcohol consumption, self-reported physical activity, socioeconomic status, prevalent cardiovascular disease, type 2 diabetes, and resting blood pressure.

Dose-response: session frequency and duration

The strongest mortality association in the KIHD cohort appears at 4–7 sessions per week of 19 minutes or longer, at traditional Finnish temperatures (80–100°C) (Laukkanen 2015 — S009). The 2023 Kunutsor updated meta-analysis is directionally consistent. For infrared-specific cabins, no equivalent multi-decade cohort exists; dose recommendations are extrapolated from traditional-sauna data and from short-term cardiovascular biomarker trials (Beever 2009 — S002).

The Kunutsor 2023 updated meta-analysis

The 2023 updated systematic review and meta-analysis by Kunutsor and Laukkanen pools KIHD with subsequent cohort and trial data published since 2015. The direction of association for all-cause and cardiovascular mortality is confirmed; effect-size estimates remain within the original confidence intervals reported in 2015. The update strengthens the case for cardiovascular benefit being robust to publication-period and additional adjustments, while not establishing causality (Kunutsor & Laukkanen, 2023).

Endothelial function and Waon therapy (Kihara 2002)

Kihara et al. (J Am Coll Cardiol, 2002) reported improved flow-mediated dilation and cardiac function in 25 patients with chronic heart failure after two weeks of daily 60°C far-infrared sauna sessions, a protocol termed Waon therapy. Flow-mediated dilation is a brachial-artery ultrasound measure of endothelial function. The trial is small and the cohort comprises patients in cardiac care; generalisation to a healthy adult population is limited but the mechanistic direction is consistent with the broader cardiovascular literature.

Blood pressure — MODERATE evidence

Blood pressure reduction with regular sauna use is biologically plausible and supported by short-term trial data, with effect sizes in the order of -8 mmHg systolic and -6 mmHg diastolic in some far-infrared trials. The longitudinal evidence base is smaller than for mortality, and trials are heterogeneous in duration, temperature and population.

Acute response vs longitudinal change

The acute blood pressure response during a sauna session is dominated by peripheral vasodilation. Systolic pressure may rise modestly at session onset and then fall as cutaneous vasculature dilates; diastolic pressure typically falls. Heart rate rises to 100–150 bpm during a 30-minute session (Hussain & Cohen, 2018). Longitudinal change in resting blood pressure is a separate question and depends on adaptation across weeks of repeated exposure rather than the within-session response.

Infrared-specific data (Beever 2009)

Beever (Can Fam Physician, 2009) summarises a series of far-infrared sauna trials in cardiovascular risk-factor populations. Reductions in resting blood pressure of approximately 8 mmHg systolic and 6 mmHg diastolic are reported across three-month interventions, with wide confidence intervals and heterogeneous trial sizes. The Hussain & Cohen 2018 systematic review describes the effect as biologically plausible and supported by acute and short-term data, with longer randomised trials still required. See infrared sauna benefits and the evidence for the full far-infrared-specific review.

Dementia and Alzheimer's disease — MODERATE evidence

The dementia association is supported by a single large cohort sub-analysis and is hedged by the realistic possibility of reverse causation. Effect sizes are striking but should be read alongside the limits of the underlying study design.

The Laukkanen 2017 KIHD sub-analysis

Laukkanen, Kunutsor and colleagues (Age Ageing, 2017) reported a hazard ratio of 0.34 (95% CI 0.16–0.71) for incident dementia in the same KIHD cohort, comparing 4–7 sauna sessions per week with one session per week. Alzheimer's-specific dementia showed a similar direction. The cohort and adjustment variables match the 2015 mortality analysis. See the KIHD cardiovascular article for the full cohort summary.

Limits of cohort data and reverse causation

Reverse causation is a specific concern in the dementia analysis: subclinical cognitive decline can reduce attendance at saunas before clinical diagnosis, creating an apparent protective association. The Laukkanen 2017 analysis applies lag-period sensitivity analyses but cannot fully exclude the effect. The evidence is graded Moderate rather than Strong on the basis of the cohort being a single population (Finnish men aged 42–60) and the reverse-causation residual.

Heat shock proteins and the longevity-pathway hypothesis — MODERATE mechanistic

Heat shock proteins (HSPs) are intracellular chaperone proteins induced by heat stress. Their induction is one of the strongest mechanistic candidates for the cardiovascular and cognitive associations observed in cohort data, and the threshold conditions for their induction are well characterised.

HSP induction threshold and timeline

Heat shock protein 72 (HSP72) is a chaperone protein induced when core body temperature reaches approximately 38.5°C for 15–30 minutes (Iguchi et al., J Athl Train, 2012 — S013). HSP72 expression rises within hours of heat exposure and persists for 24–48 hours. Patrick & Johnson (Exp Gerontol, 2021 — S012) synthesise the wider mechanistic case for HSPs, BDNF and FOXO3 pathways. Causal links to longevity outcomes in humans remain mechanistic rather than established.

FOXO3, BDNF and the Patrick & Johnson 2021 synthesis

FOXO3 is a transcription factor with well-characterised roles in cellular stress response and longevity in model organisms. BDNF is brain-derived neurotrophic factor, implicated in hippocampal neurogenesis and cognitive function. The Patrick & Johnson 2021 review synthesises the mechanistic cross-links between heat stress, HSP induction, FOXO3 activation and BDNF expression. The synthesis is mechanistic — it explains a plausible biological pathway connecting sauna exposure with the cohort findings on cardiovascular mortality and dementia — but does not constitute direct human outcome evidence. See heat shock proteins for the deep dive.

Muscle recovery and athletic performance — MODERATE evidence

Post-exercise sauna use is supported by mechanistic and short-term trial data. The 2018 Hussain & Cohen systematic review summarises the evidence as biologically plausible with measurable plasma volume expansion and HSP72 induction; outcome-grade RCTs on delayed-onset muscle soreness specifically remain sparse.

Heat acclimation (Iguchi 2012)

Iguchi and colleagues report measurable plasma volume expansion of 4–15% across 10–14 days of daily heat exposure of 30 minutes at 80°C, alongside reductions in cardiovascular strain at a given workload. Heat acclimation in this context refers to the cluster of physiological adaptations — including increased plasma volume, lower resting and exercising heart rate, and improved thermoregulation — that develop with repeated heat exposure.

Heat-cold contrast protocols

Sauna-plunge-sauna contrast protocols are widely used in athletic recovery settings. The standard pattern is three sauna rounds alternated with two cold plunges (commonly written as 15:3:15:3:15). Outcome data specific to delayed-onset muscle soreness are mechanistic and limited in size and quality. See sauna for muscle recovery for the full protocol and the evidence hedge.

Sleep, stress and HPA-axis recovery — MODERATE evidence

Sauna bathing produces an acute cortisol response that returns to baseline within hours, alongside acute and short-term effects on slow-wave sleep and subjective relaxation. Trial data are smaller in scale than the cardiovascular literature, and the strongest effects on sleep appear when sessions are timed 1–3 hours before bedtime.

Cortisol and slow-wave sleep

The hypothalamic-pituitary-adrenal (HPA) axis governs cortisol release. Acute heat stress raises cortisol during exposure; the post-session window is associated with parasympathetic rebound and reduced cortisol relative to baseline in some trial data. Slow-wave sleep — the deepest non-REM stage — has been reported to increase modestly after evening sauna exposure in small studies (Hussain & Cohen, 2018).

Timing of session relative to bedtime

Sessions concluded 1–3 hours before bedtime allow core body temperature to fall through the normal evening drop, which is associated with sleep onset. Sessions concluded within 30 minutes of bedtime may delay sleep onset because of elevated core temperature. See the dedicated sleep article for the full protocol.

Pain conditions (rheumatoid arthritis, fibromyalgia) — MODERATE evidence

Several small trials in inflammatory arthritis populations report symptomatic improvement with regular sauna use over 4–12 weeks. The effect sizes are moderate and outcome heterogeneity is high; the trial base is too small to support Strong grading.

Hussain & Cohen 2018 systematic review summary

The Hussain & Cohen 2018 systematic review summarises trials in rheumatoid arthritis, ankylosing spondylitis and fibromyalgia. Pain ratings, joint stiffness measures and quality-of-life scales improved across the trial cohort with regular sauna exposure of 30 minutes 2–3 times per week. Disease-modifying effect is not demonstrated; the benefit reported is symptomatic and short-term. Anyone with an inflammatory rheumatic condition should consult their rheumatology team before starting a regular sauna programme.

Skin and inflammatory markers — WEAK evidence

Skin-condition literature is small and heterogeneous. Psoriasis and eczema trial data conflict in direction; some patients report symptomatic improvement and others report exacerbation. Inflammatory marker data (C-reactive protein, interleukin-6) show short-term changes after acute exposure but no consistent longitudinal pattern. The evidence is graded Weak: no large trial of sufficient quality supports a definitive claim either way.

Weight loss — WEAK / INSUFFICIENT evidence

Weight-loss claims for sauna use are common in marketing copy and unsupported by the primary literature at the magnitudes typically advertised. The arithmetic of energy expenditure during a session, and the distinction between fluid loss and fat loss, both bear examination.

The thermogenic calorie math

A 30-minute session at recommended temperatures expends an estimated 50–100 kcal above resting metabolic rate (Hussain & Cohen, 2018). For context, a 70 kg adult expends roughly 1,500–1,800 kcal per day at rest, and a 15-minute brisk walk expends roughly the same 50–100 kcal as a sauna session. Sauna-attributable thermogenesis is small relative to dietary or physical-activity interventions.

Fluid loss is not fat loss

Evidence does not support sauna use as a weight-loss intervention. A 30-minute session at recommended temperatures expends an estimated 50–100 kcal above resting metabolic rate — comparable to a brisk 15-minute walk (Hussain & Cohen 2018 — S001). Acute weight loss after a session is predominantly water; mass typically returns within 24 hours of rehydration. No randomised controlled trial has demonstrated meaningful body-fat reduction attributable to sauna use independent of diet and physical activity.

Detoxification of heavy metals and persistent organics — WEAK / INSUFFICIENT

The detoxification claim is among the most commonly marketed and least well supported. The primary source typically cited — the Genuis et al. 2011 Blood, Urine, and Sweat study — does report detectable heavy metals in sweat, but the quantitative comparison with renal excretion is rarely included in the marketing summary. The honest reading is below.

What the Genuis 2011 BUS study actually reports

The Genuis et al. 2011 Blood, Urine, and Sweat study (Arch Environ Contam Toxicol — S014) confirms heavy metals (cadmium, lead, mercury, arsenic) are detectable in sweat. However, urinary excretion accounts for the majority of total elimination, and 24-hour sweat volume is small relative to 24-hour urine output. The kidneys and liver remain the dominant detoxification pathways. Marketing claims that sauna sessions "flush toxins" overstate the BUS study's quantitative findings.

Renal and hepatic pathways

The kidneys filter approximately 180 litres of plasma per day, of which 1–2 litres are excreted as urine. The liver conjugates lipophilic toxins via phase I (cytochrome P450) and phase II (glutathione, sulphation, glucuronidation) enzymatic pathways for biliary and renal excretion. Sweat excretion is a quantitatively minor pathway for most environmental toxicants. See the sauna detox myth for the full reading of the Crinnion (2011) and Genuis (2011) primary sources.

Contraindications and who should not use a sauna

Contraindications are categorised as absolute (sauna use is unsafe) or relative (sauna use requires medical clearance and caution). The list below is adapted from the Hannuksela & Ellahham 2001 American Journal of Medicine review and aligned with subsequent guidance.

Absolute contraindications

Absolute contraindications include unstable angina, recent myocardial infarction (within 2 weeks), severe aortic stenosis, decompensated heart failure, and acute febrile illness (Hannuksela & Ellahham, Am J Med, 2001 — S006). Pregnancy is a relative contraindication, particularly in the first trimester, and medical advice is required. Use of alcohol prior to or during a session is unsafe. A user with any cardiovascular, neurological or metabolic condition should consult a clinician before starting regular sauna bathing.

Relative contraindications

Relative contraindications include stable but uncontrolled hypertension, controlled cardiac arrhythmia, peripheral vascular disease, type 1 or type 2 diabetes with autonomic neuropathy, severe varicose veins, and significant skin conditions. Medical clearance from the relevant specialist is the practical pathway in these cases.

Pregnancy

Pregnancy is a relative contraindication. Maternal core hyperthermia in the first trimester has been associated with neural-tube defects in observational data, and obstetric guidance generally advises avoidance. A pregnant user or anyone trying to conceive should consult their GP or midwife before sauna bathing. This article does not constitute medical advice.

Dose-response — how often and how long

The reference dose for cardiovascular benefit in the KIHD cohort is 4–7 sessions per week of 19 minutes or longer at 80–100°C. Two to three sessions per week is associated with a smaller but still measurable mortality reduction. One session per week shows no measurable association in the cohort data. Session duration matters: sessions of 19 minutes or longer are associated with the strongest effect; sessions of 11 minutes or shorter show no measurable association. Home sauna ownership enables daily sessions in a way that gym memberships do not, and the UK context favours indoor cabins or insulated outdoor cabins given climate. See the home sauna UK buyer's guide for the practical buying context.

Choosing a sauna for these protocols (practical considerations)

The strongest cardiovascular cohort data come from traditional Finnish saunas at 80–100°C. Far-infrared cabins operate at 45–60°C with longer sessions to reach a comparable core-temperature rise. Either modality can support the dose-response patterns described above, with the hedge that long-term cohort data on infrared specifically do not yet exist. Practical buying considerations include indoor vs outdoor placement, electrical circuit requirements, and cabin sizing. See the infrared sauna UK buyer's guide and where to install a home sauna for the practical decisions.

Summary of the evidence by benefit

The evidence-grading matrix below summarises the benefit-by-benefit reading. Cardiovascular and all-cause mortality are graded Strong on the basis of the KIHD cohort and Kunutsor 2023 meta-analysis. Dementia, blood pressure, recovery, sleep, HSPs and pain are Moderate. Skin is Weak. Weight loss and detoxification are Weak to Insufficient. A user with a cardiovascular, neurological or metabolic condition should consult a clinician before starting regular sauna bathing.

Evidence-grading matrix

KIHD dose-response summary

Data adapted from Laukkanen et al., JAMA Intern Med, 2015 (n=2,315 Finnish men aged 42–60, median follow-up 20.7 years) and Laukkanen et al., Age Ageing, 2017 (dementia sub-analysis). Cohort is observational; residual confounding cannot be fully excluded.

Frequently asked questions

What are the proven health benefits of regular sauna use?

The KIHD prospective cohort (n=2,315 Finnish men aged 42–60, median follow-up 20.7 years) reports a hazard ratio of 0.60 (95% CI 0.46–0.78) for all-cause mortality in men using a sauna 4–7 times per week compared with once weekly (Laukkanen et al., JAMA Intern Med, 2015). Cardiovascular mortality hazard ratio was 0.50. The cohort is observational; residual confounding from physical activity and socioeconomic status was statistically adjusted but cannot be excluded.

How often should you use a sauna?

The strongest mortality association in the KIHD cohort appears at 4–7 sessions per week of 19 minutes or longer, at traditional Finnish temperatures (80–100°C) (Laukkanen 2015 — S009). The 2023 Kunutsor updated meta-analysis is directionally consistent. For infrared-specific cabins, no equivalent multi-decade cohort exists; dose recommendations are extrapolated from traditional-sauna data and from short-term cardiovascular biomarker trials (Beever 2009 — S002).

What does a sauna do to your body at a cellular level?

Heat shock protein 72 (HSP72) is a chaperone protein induced when core body temperature reaches approximately 38.5°C for 15–30 minutes (Iguchi et al., J Athl Train, 2012 — S013). HSP72 expression rises within hours of heat exposure and persists for 24–48 hours. Patrick & Johnson (Exp Gerontol, 2021 — S012) synthesise the wider mechanistic case for HSPs, BDNF and FOXO3 pathways. Causal links to longevity outcomes in humans remain mechanistic rather than established.

Do saunas help you lose weight?

Evidence does not support sauna use as a weight-loss intervention. A 30-minute session at recommended temperatures expends an estimated 50–100 kcal above resting metabolic rate — comparable to a brisk 15-minute walk (Hussain & Cohen 2018 — S001). Acute weight loss after a session is predominantly water; mass typically returns within 24 hours of rehydration. No randomised controlled trial has demonstrated meaningful body-fat reduction attributable to sauna use independent of diet and physical activity.

Do saunas remove toxins from the body?

The Genuis et al. 2011 Blood, Urine, and Sweat study (Arch Environ Contam Toxicol — S014) confirms heavy metals (cadmium, lead, mercury, arsenic) are detectable in sweat. However, urinary excretion accounts for the majority of total elimination, and 24-hour sweat volume is small relative to 24-hour urine output. The kidneys and liver remain the dominant detoxification pathways. Marketing claims that sauna sessions "flush toxins" overstate the BUS study's quantitative findings.

Who should not use a sauna?

Absolute contraindications include unstable angina, recent myocardial infarction (within 2 weeks), severe aortic stenosis, decompensated heart failure, and acute febrile illness (Hannuksela & Ellahham, Am J Med, 2001 — S006). Pregnancy is a relative contraindication, particularly in the first trimester, and medical advice is required. Use of alcohol prior to or during a session is unsafe. A user with any cardiovascular, neurological or metabolic condition should consult a clinician before starting regular sauna bathing.

Is infrared sauna as beneficial as traditional sauna?

The strongest cardiovascular and all-cause mortality data come from traditional Finnish saunas (KIHD; S009). Infrared-specific evidence is more limited and focused on short-term cardiovascular biomarkers (Beever 2009 — S002; Hussain & Cohen 2018 — S001). The two formats induce comparable core-temperature rises at different ambient temperatures (45–60°C infrared vs 80–100°C traditional); whether long-term outcomes match is not yet established.

Does sauna lower blood pressure long term?

Evidence is moderate. Far-infrared trials report reductions around -8/-6 mmHg over 3 months (Beever 2009 — S002), with heterogeneous effect sizes and small samples. The Hussain & Cohen 2018 systematic review (S001) describes the effect as biologically plausible and supported by acute and short-term data, with longer randomised trials still required.

Can a sauna replace exercise?

Evidence does not support sauna as a substitute for exercise. Sauna bathing and aerobic exercise induce overlapping cardiovascular responses (raised heart rate, peripheral vasodilation), and observational data in the KIHD cohort show effects in addition to physical activity (S009). Sauna is best framed as an adjunct, not a replacement. Current physical-activity guidance from the NHS remains independently applicable.

Is sauna safe in pregnancy?

Pregnancy is a relative contraindication. The Hannuksela & Ellahham review (S006) and obstetric guidance caution against use, particularly in the first trimester, because of the risk of maternal core hyperthermia. Anyone pregnant or trying to conceive should consult their GP or midwife before sauna bathing. This article does not constitute medical advice.

References

1. Hussain J & Cohen M (2018). Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review. Evidence-Based Complementary and Alternative Medicine. doi.org/10.1155/2018/1857413. [S001]
2. Beever R (2009). Far-infrared saunas for treatment of cardiovascular risk factors. Canadian Family Physician 55(7): 691–696. PMID 19602651. [S002]
3. Crinnion WJ (2011). Sauna as a valuable clinical tool for cardiovascular, autoimmune, toxicant-induced and other chronic health problems. Alternative Medicine Review 16(3): 215–225. [S003]
4. Laukkanen JA, Laukkanen T, Kunutsor SK (2018). Cardiovascular and Other Health Benefits of Sauna Bathing: A Review of the Evidence. Mayo Clinic Proceedings 93(8): 1111–1121. [S004]
5. Kihara T, Biro S, Imamura M, et al. (2002). Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. Journal of the American College of Cardiology 39(5): 754–759. [S005]
6. Hannuksela ML & Ellahham S (2001). Benefits and risks of sauna bathing. American Journal of Medicine 110(2): 118–126. [S006]
7. Laukkanen T, Khan H, Zaccardi F, Laukkanen JA (2015). Association Between Sauna Bathing and Fatal Cardiovascular and All-Cause Mortality Events. JAMA Internal Medicine 175(4): 542–548. [S009]
8. Laukkanen T, Kunutsor S, Kauhanen J, Laukkanen JA (2017). Sauna bathing is inversely associated with dementia and Alzheimer's disease in middle-aged Finnish men. Age and Ageing 46(2): 245–249. [S010]
9. Kunutsor SK, Laukkanen JA (2023). Cardiovascular and other health benefits of sauna bathing: an updated systematic review and meta-analysis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. [S011]
10. Patrick RP & Johnson TL (2021). Sauna use as a lifestyle practice to extend healthspan. Experimental Gerontology 154: 111509. [S012]
11. Iguchi M, Littmann AE, Chang SH, et al. (2012). Heat stress and cardiovascular, hormonal, and heat shock proteins in humans. Journal of Athletic Training 47(2): 184–190. [S013]
12. Genuis SJ, Birkholz D, et al. (2011). Blood, Urine, and Sweat (BUS) Study. Archives of Environmental Contamination and Toxicology 61(2): 344–357. [S014]